Potential roles for estrogen regulation of telomerase activity in aging

Annals of the New York Academy of Sciences

Volumn 1114, Issue , 2007, Pages 48-55

  Bayne, Sharyn ^a   Jones, Margaret E E ^b   Li, H E ^a   Liu, Jun Ping ^a,c  

^a MONASH UNIVERSITY   (Australia)

^b HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c MONASH UNIVERSITY MEDICAL SCHOOL   (Australia)

Author keywords

Adrenal; Aging; Estrogen; Telomerase

Indexed keywords

ESTROGEN; TELOMERASE;

AGING; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; CONFERENCE PAPER; DRUG ACTIVITY; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; IN VIVO STUDY; NONHUMAN; TISSUE REACTION;

EID: 35948935663     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1396.023     Document Type: Conference Paper

References (48)

1. GUARENTE, L. & F. PICARD. 2005. Calorie restriction: the SIR2 connection. Cell 120: 473-482.
2. TATAR, M. et al. 2003. The endocrine regulation of aging by insulin-like signals. Science 299: 1346-1351.
3. PERRY, H.M., 3rd. 1999. The endocrinology of aging. Clin. Chem. 45: 1369-1376.
4. SHAY, J.W. & W.E. WRIGHT. 2007. Hallmarks of telomeres in ageing research. J. Pathol. 211: 114-123.
5. ROSANO, G.M. et al. 2007. Menopause and cardiovascular disease: the evidence. Climacteric 10(Suppl 1): 19-24.
6. YAO, M. et al. 2007. Estrogen regulates Bcl-w and Bim expression: role in protection against beta-amyloid peptide-induced neuronal death. J. Neurosci. 27: 1422-1433.
7. ALLAIN, J.E. et al. 2002. Immortalization of a primate bipotent epithelial liver stem cell. Proc. Natl. Acad. Sci. USA 99: 3639-3644.
8. SAITO, T. et al. 1997. Proliferation-associated regulation of telomerase activity in human endometrium and its potential implication in early cancer diagnosis. Biochem. Biophys. Res. Commun. 231: 610-614.
9. MURAKAMI, J. et al. 1997. Telomerase activity in ovarian tumors. Cancer 80: 1085-1092.
10. LACEY, J.V., JR. et al. 2002. Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 288: 334-341.
11. FORSYTHE, H.L. et al. 2001. Stable association of hsp90 and p23, but not hsp70, with active human telomerase. J. Biol. Chem. 276: 15571-15574.
12. KIM, N. et al. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015.
13. ULANER, G.A. et al. 1998. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res. 58: 4168-4172.
14. WRIGHT, W. et al. 1996. Telomerase activity in human germline and embryonic tissues and cells. Dev. Genet. 18: 173-179.
15. HU, B.T. et al. 1997. Telomerase is up-regulated in human germinal center B cells in vivo and can be re-expressed in memory B cells activated in vitro. J. Immunol. 159: 1068-1071.
16. NORRBACK, K.F. et al. 1996. Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas. Blood 88: 222-229.
17. WENG, N.P. et al. 1997. Telomere lengthening and telomerase activation during human B cell differentiation. Proc. Natl. Acad. Sci. USA 94: 10827-10832.
18. LEHNERT, H. et al. 1993. Extrapituitary effects of corticotropin-releasing hormone and thyrotropin-releasing hormone. Neuropsychobiology 28: 54-61.
19. TANAKA, M. et al. 1998. Expression of telomerase activity in human endometrium is localized to epithelial glandular cells and regulated in a menstrual phase-dependent manner correlated with cell proliferation. Am. J. Pathol. 153: 1985-1991.
20. BURGER, A.M. et al. 1997. Telomerase activity in normal and malignant mammalian tissues: feasibility of telomerase as a target for cancer chemotherapy. Br. J. Cancer 75: 516-522.
21. SHAY, J.W. & S. BACCHETTI. 1997. A survey of telomerase activity in human cancer. Eur. J. Cancer 33: 787-791.
22. FULNECKOVA, J. & J. FAJKUS. 2000. Inhibition of plant telomerase by telomere-binding proteins from nuclei of telomerase-negative tissues. FEBS Lett. 467: 305-310.
23. KARLSEDER, J. et al. 2002. Senescence induced by altered telomere state, not telomere loss. Science 295: 2446-2449.
24. OLOVNIKOV, A.M. 1973. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J. Theor. Biol. 41: 181-190.
25. BLACKBURN, E. 2001. Switching and signaling at the telomere. Cell 106: 661-673.
26. VAZIRI, H. et al. 1994. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc. Natl. Acad. Sci. USA 91: 9857-9860.
27. ZIMMERMANN, S. & U.M. MARTENS. 2005. Telomere dynamics in hematopoietic stem cells. Curr. Mol. Med. 5: 179-185.
28. HIYAMA, K. et al. 1995. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol. 155: 3711-3715.
29. LIU, K. et al. 1999. Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes [In Process Citation]. Proc. Natl. Acad. Sci. USA 96: 5147-5152.
30. KYO, S. et al. 1999. Estrogen activates telomerase. Cancer Res. 59: 5917-5921.
31. SARKAR, P. et al. 2006. Activation of telomerase in BeWo cells by estrogen and 2,3,7,8-tetrachlorodibenzo-p-dioxin in co-operation with c-Myc. Int. J. Oncol. 28: 43-51.
32. MISITI, S. et al. 2000. Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells [In Process Citation]. Mol. Cell Biol. 20: 3764-3771.
33. LING, S. et al. 2006. Effects of 17beta-estradiol on growth and apoptosis in human vascular endothelial cells: Influence of mechanical strain and tumor necrosis factor-alpha. Steroids 71: 799-808.
34. DOSHIDA, M. et al. 2006. Raloxifene increases proliferation and up-regulates telomerase activity in human umbilical vein endothelial cells. J. Biol. Chem. 281: 24270-24278.
35. IMANISHI, T. et al. 2005. Estrogen reduces endothelial progenitor cell senescence through augmentation of telomerase activity. J. Hypertens. 23: 1699-1706.
36. CHENG, A.S.L. et al. 2006. Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-[alpha] responsive promoters. Mol. Cell 21: 393-404.
37. KAWAGOE, J. et al. 2003. Raloxifene inhibits estrogen-induced up-regulation of telomerase activity in a human breast cancer cell line. J. Biol. Chem. 278: 43363-43372.
38. KIMURA, A. et al. 2004. Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines. Oncogene 23: 4505-4515.
39. LI, H. et al. 2005. Telomerase down-regulation does not mediate PC12 pheochromocytoma cell differentiation induced by NGF, but requires MAP kinase signalling. J. Neurochem. 95: 891-901.
40. WONG, K.K. et al. 2003. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature 421: 643-648.
41. WILLIAMS, C.D. et al. 2001. A prospective, randomized study of endometrial telomerase during the menstrual cycle. J. Clin. Endocrinol. Metab. 86: 3912-3917.
42. YOKOYAMA, Y. et al. 1998. Telomerase activity in the human endometrium throughout the menstrual cycle. Mol. Hum. Reprod. 4: 173-177.
43. KYO, S. et al. 1997. Telomerase activity in human endometrium. Cancer Res. 57: 610-614.
44. BUCKLER, H. 2005. The menopause transition: endocrine changes and clinical symptoms. J. Br. Menopause Soc. 11: 61-65.
45. KATO, K. et al. 2002. Contribution of estrogen receptor alpha to oncogenic K-Ras-mediated NIH3T3 cell transformation and its implication for escape from senescence by modulating the p53 pathway. J. Biol. Chem. 277: 11217-11224.
46. FISHER, C.R. et al. 1998. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc. Natl. Acad. Sci. USA 95: 6965-6970.
47. CHADENEAU, C. et al. 1995. Telomerase activity in normal and malignant murine tissues. Oncogene 11: 893-898.
48. PROWSE, K.R. & C.W. GREIDER. 1995. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc. Natl. Acad. Sci. USA 92: 4818-4822.